An Emerging Role for Epigenetics in Cerebral Palsy

Area of Science:

• Neurology
• Genetics
• Developmental Biology

Background:

• Cerebral palsy (CP) is a common motor disability resulting from early brain damage.
• Spastic CP, the most frequent type, causes muscle issues like high tone, poor growth, and movement difficulties.
• Current treatments for CP's musculoskeletal effects are limited in predictability.

Purpose of the Study:

• To review evidence supporting the role of epigenetics in the musculoskeletal manifestations of spastic CP.
• To highlight the need for advanced analytical approaches, including omics technologies, for personalized CP management.

Main Methods:

• Literature review of studies on cerebral palsy and muscle function.
• Analysis of emerging evidence linking epigenetic modifications to CP-related muscle alterations.
• Synthesis of current understanding of molecular pathways involved in spastic CP muscle pathology.

Main Results:

• Growing evidence suggests epigenetic phenomena contribute significantly to altered muscle function in spastic CP.
• Understanding these epigenetic mechanisms is crucial for addressing muscle-related debilitation in CP.
• Current knowledge of molecular pathways in CP muscle dysfunction remains incomplete.

Conclusions:

• Epigenetic factors are increasingly recognized as key contributors to the musculoskeletal problems seen in spastic cerebral palsy.
• Further research into the molecular and epigenetic underpinnings of CP is essential for developing more effective and personalized therapeutic strategies.
• This review emphasizes the potential of epigenetics to offer novel targets for intervention in managing spastic CP.